A detailed history of Harvey Capital Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Harvey Capital Management Inc holds 6,978 shares of NVO stock, worth $733,108. This represents 0.21% of its overall portfolio holdings.

Number of Shares
6,978
Previous 7,050 1.02%
Holding current value
$733,108
Previous $1.01 Million 17.5%
% of portfolio
0.21%
Previous 0.26%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$119.07 - $145.42 $8,573 - $10,470
-72 Reduced 1.02%
6,978 $830,000
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $719,875 - $958,235
7,050 New
7,050 $905,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Harvey Capital Management Inc Portfolio

Follow Harvey Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvey Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Harvey Capital Management Inc with notifications on news.